Skip to main content
Caplight Logo









Domainex Ltd

Domainex Ltd

Private
CambridgeHealthcare & Life Scienceshttps://www.domainex.co.uk/

Last Round

Grant

Jan 23, 2018

Total Funding Raised

$5.2M

Company Overview

Domainex Ltd is a drug discovery company that provides integrated medicines research services to pharmaceutical, biotechnology, and academic partners globally.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts, Revenue Share

AI Layer

Application

Keywords

contract research organizationCROdrug discovery servicesintegrated drug discoverysmall molecule drug discoverymedicinal chemistrypre-clinical drug discoveryoutsourced R&Dcomputational chemistryAI drug discoverycomputer-aided drug designCADDfragment-based drug discoveryFBDDstructural biologyprotein productiondrug metabolism and pharmacokineticsDMPKassay developmentmembrane protein services

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Domainex Ltd Comparables

Compare Domainex Ltd with similar companies based on industry and business-model similarity.

Domainex Ltd comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Sygnature Discovery
88%
BioAscent
85%
Concept Life Sciences
83%

Domainex Ltd Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJan 23, 2018
GrantNov 21, 2014
VC RoundDec 1, 2012
GrantNov 1, 2011
VC RoundJun 1, 2010
Series A
Apr 25, 2008

Domainex Ltd Investors

Notable investors and investment history

Domainex Ltd investors
InvestorRounds
Longbow CapitalVC Round, Series A
Innovate UKGrant
Medical Research CouncilGrant
UCL BusinessVC Round
Takeda VenturesVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 23, 2018

    $160K grant received from Innovate UK.

  • Nov 21, 2014

    $2.2M grant round led by Innovate UK.

Domainex Ltd Filings

Explore SEC and related filing metadata, where available.

Domainex Ltd filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Domainex Ltd's valuation, stock price, and market status.

Is Domainex Ltd a public or private company?

Domainex Ltd is a private company.

What is the current stock price of Domainex Ltd?

Domainex Ltd is a private company with no public stock price. No recent secondary market data is available.

How much is Domainex Ltd worth (valuation)?

Valuation information for Domainex Ltd is not publicly available.

Can I buy Domainex Ltd stock?

Domainex Ltd shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Domainex Ltd's last funding round?

Domainex Ltd's most recent funding round was Grant on January 23, 2018.

Who are the main investors in Domainex Ltd?

Key investors in Domainex Ltd include Longbow Capital, Innovate UK.

Will Domainex Ltd IPO soon?

No public IPO plans have been announced for Domainex Ltd.

How can I track Domainex Ltd secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Domainex Ltd's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersCambridge
Employee Range76
Year Founded2001
Last FundingJan 23, 2018

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?